Saturday, 14 February 2009

Recal D



calcium carbonate, cholecalciferol, magnesium oxide, boric acid, folic acid, pyridoxine hydrochloride and cyanocobalamin

Dosage Form: chewable wafer
Recal D WAFERS CHEWABLE WAFERS

INDICATIONS AND USAGE:


Recal D Wafers are indicated to help, along with diet, the treatment of calcium deficiency, skeletal weakness and osteoporosis. Recal D Wafers supplementation may be beneficial to individuals who have an insufficient dietary intake of the nutrients in this formulation. Calcium and vitamin D supplementation may be useful in both preventing and treating osteoporosis. Vitamin D supplementation may be beneficial to those who are institutionalized and/or have reduced exposure to sunlight. Folic acid, vitamin B6 and vitamin B12 may help reduce the risk of cardiovascular disease by lowering blood levels of homocysteine. If dietary intake of calcium is inadequate, patients currently taking bisphosphonates for osteoporosis treatment should be instructed to take calcium and vitamin D daily.

DOSAGE AND ADMINISTRATION:


Chew one wafer twice daily or as prescribed by a physician.

DOSAGE FORMS AND STRENGTHS:


Recal D Wafers are supplied in bottles of 60 wafers, NDC 68032-270-60 and are brown, round shaped wafers, debossed on scored side with “RE 270.”



CONTRAINDICATIONS:


Recal D Wafers are contraindicated in patients with hypersensitivity to any of its ingredients. Calcium and vitamin D supplementation is contraindicated in those with hypercalcemia or conditions that may lead to hypercalcemia and those who form calcium containing stones are generally advised not to take supplemental calcium. Used together, iron and calcium may inhibit the absorption of iron. Concurrent use of quinolones or tetracyclines with calcium may decrease the absorption of these medications. Folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. The use of folic acid doses above one milligram per day may precipitate or exacerbate the neurological damage of vitamin B12 deficiency. High doses of folic acid may result in decreased serum levels of the anticonvulsant drugs: carbamazepine, fosphenytoin, phenytoin, phenobarbital, valproic acid.

WARNINGS AND PRECAUTIONS:


Keep this and all medications out of the reach of children. Folic acid, especially in doses above 0.1 mg daily, may obscure pernicious anemia, in that hematologic remission may occur while neurological manifestations remain progressive.

ADVERSE REACTIONS:


Adverse reactions have been reported with specific vitamins and minerals, but generally at levels substantially higher than those in Recal D Wafers. However, allergic and/or idiosyncratic reactions to vitamins even at lower potencies or any ingredient are possible.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

DRUG INTERACTIONS:


As little as 5 mg of pyridoxine (vitamin B6) daily can decrease the efficacy of levodopa. Recal D Wafers are not recommended for patients undergoing levodopa therapy.

USE IN SPECIFIC POPULATIONS:


Pregnancy: Under the supervision of a physician only.

Pediatric Use: Not recommended for pediatric use.

DESCRIPTION:


Recal D Wafers are a chewable calcium and folic acid formula with Vitamin D, magnesium and other nutrients to help, along with diet, the treatment of calcium deficiency, skeletal weakness and osteoporosis. Recal D Wafers supplementation may be beneficial to individuals who have an insufficient dietary intake of the nutrients in this formulation. Calcium and vitamin D supplementation may be useful in both preventing and treating osteoporosis.


Each chocolate-flavored chewable wafer contains:

Active Ingredients:

Calcium Carbonate (Elemental 500mg)....................................1342 mg

Vitamin D3 (Cholecalciferol) ........................................................ 300 IU

Magnesium (Magnesium Oxide) .................................................50 mg

Boron ...................................................................................... 250 mcg

Folic Acid ....................................................................................1.0 mg

Vitamin B6 (Pyridoxine HCl) .........................................................10 mg

Vitamin B12 (Cyanocobalamin) ................................................ 125 mcg


Inactive Ingredients: Acacia, Aspartic Acid, Black Iron Oxide, Citric Acid, Chocolate Flavor, Croscarmellose Sodium, Dicalcium Phosphate, Glycine, Magnesium Stearate, Maltodextrin, Red Iron Oxide, Sodium Lauryl Sulfate, Soy Polysaccharide, Stearic Acid and Sugar.

HOW SUPPLIED:


Brown, round shaped wafer, debossed on scored side with “RE 270” in bottles of 60 wafers, NDC 68032-270-60.


Store at room temperature, 15-30°C (59-86°F). Protect from light and moisture.


Rx Only









Recal D  
calcium carbonate, cholecalciferol, magnesium oxide, boric acid, folic acid, pyridoxine hydrochloride, cyanocobalamin  wafer










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)68032-270
Route of AdministrationORALDEA Schedule    


























Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CALCIUM CARBONATE (CALCIUM)CALCIUM CARBONATE1342 mg
CHOLECALCIFEROL (CHOLECALCIFEROL)CHOLECALCIFEROL300 [iU]
MAGNESIUM OXIDE (MAGNESIUM)MAGNESIUM OXIDE50 mg
BORIC ACID (BORIC ACID)BORIC ACID250 ug
FOLIC ACID (FOLIC ACID)FOLIC ACID1 mg
PYRIDOXINE HYDROCHLORIDE (PYRIDOXINE)PYRIDOXINE HYDROCHLORIDE10 mg
CYANOCOBALAMIN (CYANOCOBALAMIN)CYANOCOBALAMIN125 ug






























Inactive Ingredients
Ingredient NameStrength
ACACIA 
ASPARTIC ACID 
FERROSOFERRIC OXIDE 
CITRIC ACID MONOHYDRATE 
CROSCARMELLOSE SODIUM 
ANHYDROUS DIBASIC CALCIUM PHOSPHATE 
GLYCINE 
MAGNESIUM STEARATE 
MALTODEXTRIN 
SODIUM LAURYL SULFATE 
SOYBEAN 
STEARIC ACID 
SUCROSE 


















Product Characteristics
Colorbrown (RE 270)Score2 pieces
ShapeROUNDSize23mm
FlavorImprint CodeRE;270
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
168032-270-6060 WAFER In 1 BOTTLENone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other01/14/200910/31/2012


Labeler - River's Edge Pharmaceuticals, LLC (133879135)
Revised: 04/2011River's Edge Pharmaceuticals, LLC




More Recal D resources


  • Recal D Side Effects (in more detail)
  • Recal D Dosage
  • Recal D Use in Pregnancy & Breastfeeding
  • Recal D Drug Interactions
  • Recal D Support Group
  • 0 Reviews for Recal D - Add your own review/rating


Compare Recal D with other medications


  • Vitamin/Mineral Supplementation and Deficiency

No comments:

Post a Comment